Valuation
Is the price right?2/2 inputs reported · High confidence
Held back by:
- ▼ P/B
Behind the score
Earnings yield (P/E) and book yield (P/B) versus other banks and insurers.
Bringing the fundamentals into focus…
Price as of close on Nov 3, 2026 · Financials updated Sep 30, 2026
2/2 inputs reported · High confidence
Held back by:
Earnings yield (P/E) and book yield (P/B) versus other banks and insurers.
1/1 inputs reported · High confidence
Stronger than most peers on:
Earnings-per-share growth versus other banks and insurers.
2/2 inputs reported · High confidence
Stronger than most peers on:
Return on equity and return on assets versus other banks and insurers.
Not rated for banks and insurers: debt and share-price swings say little about their risk. We leave it blank rather than fill the gap with a made-up middle value.
Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.
No major changes
| Previous quarter | Latest quarter | Change | |
|---|---|---|---|
| Net income (12 months) | 32.2M USD | 35.8M USD | +11.3% |
| Free cash flow (12 months) | 22.2M USD | 31.7M USD | +42.8% |
| Cash | 62.9M USD | 135.5M USD | +115.6% |
| Shares outstanding | 7.0M | 7.0M | −0.1% |
From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.
Valuations in Banks - Regional are within their usual range since 2016.
| Key ratios | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | Change |
|---|---|---|---|---|---|---|
| Net margin | — | — | — | — | — | — |
| Return on assets (ROA) | 1.3% | 1.6% | 1.8% | 1.8% | 1.3% | ▼ 0.4 pts |
| Return on equity (ROE) | 15.7% | 22.2% | 20.2% | 16.1% | 11.3% | ▼ 4.7 pts |
| Debt to equity | 0.00× | 0.00× | — | — | — | — |
Price history is added with the daily price update and will appear after the next one.